• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[膀胱浅表肿瘤的自然史及预后因素]

[Natural history and prognostic factors of superficial tumors of the bladder].

作者信息

Hoznek A, Bellot J, Abbou C C, Chopin D K

机构信息

Service d'Urologie, Hôpital Henri-Mondor, Creteil.

出版信息

Ann Urol (Paris). 1993;27(1):20-3.

PMID:8470875
Abstract

Forty-five patients with superficial bladder cancer managed by transurethral resection alone were studied longitudinally to identify factors associated with progression. Tumor grade, multiple tumor foci, and time to first recurrence were closely correlated with progression. Findings from this study are compared with previous reports. These data are useful to identify patients requiring more aggressive therapy, including intravesical anticancer drugs and BCG, and monitoring with closer-spaced cystoscopies.

摘要

对45例仅接受经尿道切除术治疗的浅表性膀胱癌患者进行纵向研究,以确定与疾病进展相关的因素。肿瘤分级、多发肿瘤灶以及首次复发时间与疾病进展密切相关。将本研究结果与既往报告进行比较。这些数据有助于识别需要更积极治疗的患者,包括膀胱内抗癌药物和卡介苗治疗,以及通过更密集的膀胱镜检查进行监测。

相似文献

1
[Natural history and prognostic factors of superficial tumors of the bladder].[膀胱浅表肿瘤的自然史及预后因素]
Ann Urol (Paris). 1993;27(1):20-3.
2
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.高危浅表性膀胱肿瘤患者膀胱内卡介苗治疗失败后的膀胱切除术:术前前列腺受累作为一个预后因素。
Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7.
3
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
4
Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.膀胱原发性浅表性移行细胞癌的预后因素:一项回顾性队列研究。
Chin Med J (Engl). 2006 Nov 5;119(21):1821-8.
5
Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.浅表性膀胱肿瘤患者的临床全尿路上皮疾病:治疗意义。
J Urol. 2002 May;167(5):2007-11.
6
Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.p53、bcl-2和Ki-67在高危浅表性膀胱癌中的预后意义
Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.
7
The treated natural history of high risk superficial bladder cancer: 15-year outcome.高危浅表性膀胱癌的治疗后自然病程:15年随访结果
J Urol. 1997 Jul;158(1):62-7. doi: 10.1097/00005392-199707000-00017.
8
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.高危浅表性膀胱癌的再次经尿道切除术可改善对卡介苗治疗的初始反应。
J Urol. 2005 Dec;174(6):2134-7. doi: 10.1097/01.ju.0000181799.81119.fc.
9
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果:日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
10
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.低剂量卡介苗灌注治疗Ta3期膀胱肿瘤的复发、进展及疗效
J Urol. 2000 Jan;163(1):63-7.